Novo Nordisk referenced the FDA’s considerations in its lawsuit announcement on Monday, saying Hims & Hers’ compounded medicine “may contain dangerous impurities or incorrect amounts of active ingredients, which can result in life-threatening immune responses”.
https://www.bbc.com/news/articles/cddn4z54qe8o?at_medium=RSS&at_campaign=rss